Cerebrospinal fluid examination in a case of childhood orbital granulocytic sarcoma

Diagnostic Cytopathology
P M GirardotP Vielh

Abstract

The diagnosis of a case of childhood orbital granulocytic sarcoma, initially classified as a poorly-differentiated malignant tumor, was finally considered at the time of relapse following primary treatment with chemotherapy and local irradiation. At this time, systematic cerebrospinal fluid examination showed numerous blast cells with Auer rods, consistent with the diagnosis of meningeal acute myeloid leukemia of M2 type, and concomitant biopsy of the tumor indicated the diagnosis of chloroma. Reevaluation of the primary biopsy confirmed this diagnosis.

References

Dec 12, 1991·The New England Journal of Medicine·C H PuiJ T Sandlund
Apr 1, 1991·American Journal of Clinical Pathology·S van VeenH C Kluin-Nelemans
Jun 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M EshghabadiI Carr
Jan 1, 1989·The American Journal of Pediatric Hematology/oncology·W A Bleyer
Sep 1, 1988·The American Journal of Surgical Pathology·F R DaveyD Y Mason
Dec 15, 1986·Cancer·J M MeisJ T Manning
Jan 1, 1983·Medical and Pediatric Oncology·D J GanickW Borcherding
Oct 1, 1995·American Journal of Clinical Pathology·L Quintanilla-MartínezN L Harris
Oct 1, 1993·The American Journal of Surgical Pathology·S T TraweekR K Brynes
Jun 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C SandovalD R Head
Apr 1, 1993·American Journal of Clinical Pathology·S L Perkins, C R Kjeldsberg

❮ Previous
Next ❯

Citations

Aug 17, 1999·Clinical and Laboratory Haematology·F Ravandi-KashaniF J Giles

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.